Stockreport

Nuvation Bio Inc. (NUVB) and Eisai Get EMA Validation for Taletrectinib [Yahoo! Finance]

Nuvation Bio Inc. Class A  (NUVB) 
PDF announced that the European Medicines Agency (EMA) validated the Marketing Authorisation Application (MAA) for Taletrectinib, which is marketed as IBTROZI in the US and [Read more]